Sumitomo Mitsui Trust Group’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-5,812
Closed -$261K 1101
2020
Q2
$261K Buy
+5,812
New +$253K ﹤0.01% 1069
2019
Q2
Sell
-16,378
Closed -$439K 1011
2019
Q1
$439K Sell
16,378
-7,193
-31% -$218K ﹤0.01% 907
2018
Q4
$703K Buy
+23,571
New +$734K ﹤0.01% 838

Other funds holding ATRC

Sumitomo Mitsui Trust Group's ATRC Position: Q3 2020 in Review

Sumitomo Mitsui Trust Group sold out of AtriCure (ATRC) in Q3 2020, closing a stake of 5,812 shares — an estimated $261K sold.

Sumitomo Mitsui Trust Group first reported a position in ATRC in Q4 2018 and held it in 3 quarters. The position peaked at $703K in Q4 2018. 183 funds tracked by Wall St. Rank hold ATRC as of Q3 2020.

  • Sumitomo Mitsui Trust Group reported no remaining AtriCure position as of Q3 2020 after selling out during the quarter.
  • Sumitomo Mitsui Trust Group sold 5,812 AtriCure shares in Q3 2020, an estimated $261K.
  • Sumitomo Mitsui Trust Group first reported a position in AtriCure in Q4 2018 and held it in 3 quarters.
  • Sumitomo Mitsui Trust Group's AtriCure position peaked at $703K in Q4 2018.
  • 183 funds tracked by Wall St. Rank held AtriCure as of Q3 2020.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q3 2020, filed 30 Oct 2020.